Jazz EVP shares withheld for RSU tax
Jazz Pharmaceuticals EVP & Chief Legal Officer Neena M. Patil had 2,678 Ordinary Shares withheld on June 30, 2026 to cover taxes from vesting restricted stock units.
Rhea-AI Filing Summary
Jazz Pharmaceuticals EVP & Chief Legal Officer Neena M. Patil had 2,678 Ordinary Shares withheld on June 30, 2026 to cover taxes from vesting restricted stock units. The shares were not sold on the open market but used to satisfy tax obligations.
After this tax-withholding disposition, Patil directly holds 48,871 Ordinary Shares. This type of transaction is routine for equity-based compensation and does not represent a discretionary purchase or sale decision.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Ordinary Shares | 2,678 | $237.72 | $637K |
Footnotes (1)
- F1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Key Figures
Key Terms
restricted stock units financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Neena M. Patil?
Was the Jazz Pharmaceuticals (JAZZ) Form 4 a stock sale by the insider?
What does a tax-withholding disposition mean for Jazz Pharmaceuticals (JAZZ) investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.